Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

MS risk factors (4%) included mononucleosis, viral CNS infection, tobacco abuse, head injury, and vitamin D deficiency, while pregnancy, measles, and viral warts were associated with a lower MS diagnosis risk.

Source: Associations Between Clinical Conditions and Multiple Sclerosis Diagnosis. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Multiple reported designs.

Multiple reported designs

More than one design is explicitly reported; examine the supporting methods.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Given the availability of the participants' diagnoses recorded both prior and after their recruitment in the study, we conducted our analysis based on a retrospective cohort study design.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Timing and Predictive Value of Clinical Conditions Preceding Multiple Sclerosis in the UK Biobank

Multiple reported designs · Annals of Clinical and Translational Neurology · 2025

Original publication title

Timing and Predictive Value of Clinical Conditions Preceding Multiple Sclerosis in the UK Biobank

Andrea Nova; Teresa Fazia; Giovanni Di Caprio; Davide Gentilini; Luisa Bernardinelli; Roberto Bergamaschi

© 2025 The Author(s). Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our findings highlight early conditions and diagnostic trajectories of MS, supporting the existence of a prodromal phase. These insights could improve MS prediction and facilitate earlier detection, particularly for late‐onset cases.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Multiple sclerosis (MS) patients often experience a higher incidence of clinical conditions before diagnosis, suggesting a prodromal phase. However, their predictive value and temporal trajectories remain underexplored. We investigated these aspects using the large UK Biobank's population‐based cohort, which provided clinical history through ICD‐10 diagnosis codes.

Source: Objectives

Abstract: What methods does the paper describe?

We assessed associations between 600 clinical conditions and MS risk in 477,421 individuals using Cox models adjusted for demographics, smoking, and MS polygenic risk score (MS‐PRS). Statistically significant conditions were included in a LASSO Cox regression (five‐fold cross‐validation on 70% training set) to identify key predictors, with performance assessed by the C‐index and age‐dependent area under the curve (AUC) in the 30% test set. Lastly, temporal trajectories of MS‐associated conditions were analyzed in MS cases.

Source: Methods

Abstract: Results

We identified 192 conditions associated with MS, of which only ~20% were onset symptoms. Integrating these conditions into a predictive model already including demographics and smoking, improved the C‐index from 0.65 to 0.71. Among the 30 model‐selected best predictors, ~25% were prodromal conditions, including neuromuscular diseases, thromboembolism, and depression which typically occurred more than five years before MS diagnosis. Including MS‐PRS further increased the C‐index to 0.78, with an age‐dependent AUC exceeding 0.80 in individuals over 50 years. Trajectory analysis highlighted migraine as a common early diagnosis, often followed by hypertension, depression, and dorsalgia.

Source: Results

Abstract: Interpretation

Our findings highlight early conditions and diagnostic trajectories of MS, supporting the existence of a prodromal phase. These insights could improve MS prediction and facilitate earlier detection, particularly for late‐onset cases.

Source: Interpretation
Authors’ abstract

ABSTRACT

Objectives

Multiple sclerosis (MS) patients often experience a higher incidence of clinical conditions before diagnosis, suggesting a prodromal phase. However, their predictive value and temporal trajectories remain underexplored. We investigated these aspects using the large UK Biobank's population‐based cohort, which provided clinical history through ICD‐10 diagnosis codes.

Methods

We assessed associations between 600 clinical conditions and MS risk in 477,421 individuals using Cox models adjusted for demographics, smoking, and MS polygenic risk score (MS‐PRS). Statistically significant conditions were included in a LASSO Cox regression (five‐fold cross‐validation on 70% training set) to identify key predictors, with performance assessed by the C‐index and age‐dependent area under the curve (AUC) in the 30% test set. Lastly, temporal trajectories of MS‐associated conditions were analyzed in MS cases.

Results

We identified 192 conditions associated with MS, of which only ~20% were onset symptoms. Integrating these conditions into a predictive model already including demographics and smoking, improved the C‐index from 0.65 to 0.71. Among the 30 model‐selected best predictors, ~25% were prodromal conditions, including neuromuscular diseases, thromboembolism, and depression which typically occurred more than five years before MS diagnosis. Including MS‐PRS further increased the C‐index to 0.78, with an age‐dependent AUC exceeding 0.80 in individuals over 50 years. Trajectory analysis highlighted migraine as a common early diagnosis, often followed by hypertension, depression, and dorsalgia.

Interpretation

Our findings highlight early conditions and diagnostic trajectories of MS, supporting the existence of a prodromal phase. These insights could improve MS prediction and facilitate earlier detection, particularly for late‐onset cases.

Publication and source details

Original title: Timing and Predictive Value of Clinical Conditions Preceding Multiple Sclerosis in the UK Biobank

Andrea Nova; Teresa Fazia; Giovanni Di Caprio; Davide Gentilini; Luisa Bernardinelli; Roberto Bergamaschi

Annals of Clinical and Translational Neurology · 2025

* Correspondence:
Andrea Nova (andrea.nova01@universitadipavia.it)
© 2025 The Author(s). Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T04:19:28.089210+00:00

DOI: 10.1002/acn3.70119 · PMC12516241